Mentions
Extended reach
Total likes
Video views
AI synopsis
The overall tone reflects a strong interest in the health benefits of CoQ10, with posts emphasizing improvements in liver and cardiovascular functions, such as 'reduces liver steatosis' and 'improves endothelial, vascular and left ventricle myocardial function.' The use of phrases like 'Six-month supplementation with high dose CoQ10' and references to specific health outcomes demonstrate active engagement and acknowledgment of the potential impact, though some users express curiosity rather than full endorsement.
Most discussions acknowledge the positive effects of CoQ10 reported in the study, though some questions or skepticism are present.
Posts demonstrate high interest by highlighting the potential health benefits and mentioning specific improvements like liver health and cardiovascular functions.
Participants actively discuss the findings, referencing the dosage and implications, indicating a moderate level of deep engagement.
The discussions suggest recognition of the study’s significance for treating conditions like MASLD, potentially influencing future research or treatments.
240 mg CoQ10 for 6 mths in patients with Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD), the new name for NAFLD, reduces liver steatosis and improves endothelial, vascular and left ventricle myocardial function. https://t.co/ZNO5gJtZd5
CoQ10! Six-month supplementation with high dose coenzyme Q10 improves liver steatosis ... - https://t.co/E38nz4b17A
Would you like to eliminate fatty liver? This supplement burns fat from the liver in weeks and restores liver function. Taking just one capsule a day can also reduce cholesterol, blood pressure, and triglycerides…
Six months of high-dose coenzyme Q10 supplementation improved liver steatosis, endothelial, vascular, and myocardial function, reducing cardiovascular risks in patients with MASLD, as shown in a randomized double-blind…
@theliverdr What are your thoughts about these two studies regarding CoQ10 and its impact on non-alcohol fatty liver? Thank you. https://t.co/zQkA54FrYe https://t.co/PNshUgUWs9
240 mg CoQ10 for 6 mths in patients with Metabolic-dysfunction Associated Steatotic Liver Disease (MASLD), the new name for NAFLD, reduces liver steatosis and improves endothelial, vascular and left ventricle myocardial function. https://t.co/ZNO5gJtZd5
CoQ10! Six-month supplementation with high dose coenzyme Q10 improves liver steatosis ... - https://t.co/E38nz4b17A